ACR24 - Day2d

Save

Assessment of axSpA:Dr. Antoni Chan Defining Difficult to Manage axSpA:Dr. Lihi DISH in SpA:Dr. Sheila Reyes Generative AI in Rheumatology: The Good, The Bad, The Ugly:Dr. Akhil Sood Native Americans with RA Die Young:Dr. Eric Dein Precision Immunotherapy in Axial SpA:Dr. Marina Magrey When, What and How Long to Treat GCA & PMR:Dr.

ACR24 - Day2c

Save

A Fibroblast Renaissance:Dr. Andrea Fava A useful urinary biomarker for lupus nephritis:Dr. Andrea Fava ACR Advocacy Update:Dr. Eric Dein talks with Dr. Christina Downey, ACR Government Affairs Committee, and Dr. Kaitlyn Brittan, RheumPAC Carotid Doppler Ultrasound Screening in Axial SpA:Dr. Trish Harkins discussed with Dr.

RheumNow Day 2 Recap: ACR Convergence 2024 Highlights

Save

Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

ACR24 - Day2b

Save

JAKi Studies at ACR:Dr. Peter Nash Palliative Care in Rheumatology:Dr. Jiha Lee talks with Dr. Shannon Herndon Estimating Inflammation, Damage and Patient Distress:Dr. Jack Cush talks with Dr. Ted Pincus Methotrexate and the Gut Microbiome:Dr. Jonathan Kay talks with Dr. Rebecca Blank Poly-treatment of Polymyalgia Rheumatica?:Dr.

ACR24 - Day2a

Save

Bimekizumab in PsA Showed Sustained Reductions in Disease Impact:Dr. Eric Dein talks with Dr. Ana-Marie Orbai CAR-T Therapy and Lupus:Dr. Akhil Sood talks with Dr. Chris Wincup Cycling vs Switching after TNFi Failure in axSpA:Dr. Lihi Eder Difficult to manage AxSpA:Dr. Sheila Reyes talks with Dr. Denis Poddubnyy Gender Differences in AxSpA:Dr.

RheumNow Day 1 Recap ACR Convergence 2024 Highlights

Save

Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

ACR24 - Day1c

Save

Aging Gracefully in Managing Rheumatic Diseases:Dr. Mrinalini Dey interviews Dr. Elena Myasoedova Apremilast Benefits and Risks in PsA:Dr. Akhil Sood Assessing ASAS Criteria: CLASSIC Study Results:Dr. Adela Castro Assessment and management of axSpA:Dr. Antoni Chan Disease Activity in RA-ILD:Dr.

ACR24 - Day1b

Save

JAK-pot! How fast do DMARDs work?:Dr. Mike Putman and Dr. Kim Lauper Paraoxonase-1: Possible Biomarker for Progression to RA:Dr. Jonathan Kay Potential Impact of Weight Loss Drugs in Rheumatic Diseases:Dr. Arthur Kavanaugh PREDICT-SpA: Evaluating the influence of gender on disease assessment tools:Dr.

ACR2024 - Day1a

Save

Are we under-monitoring in scleroderma ILD?:Dr. Janet Pope Cancer Survival in RA:Dr. Eric Dein interviews Joshua Hsieh Continuing or Stopping Low Dose Glucocorticoids in GPA:Dr. Mike Putman COVID Associated Immune Disease:Dr. Len Calabrese How to Master ACR Meetings:Dr. Cush

ACR 2024 Preview Podcast (11.15.2024)

Save

ACR 2024 starts tomorrow; here are a few previews of Abstracts to be presented. Along with my recommendations of sessions you don’t want to miss.

Dr. Quotes (11.8.2024)

Save

Dr. Jack Cush reviews the news and journal reports from this past week from RheumNow.com

Minimizing Steroids in Lupus Sponsored by AstraZeneca Medical Affairs Nov 01, 2024

Save

Minimizing steroid use in patients with SLE. Learn more about when, why, and how to taper steroids and listen to experts, Dr Michelle Petri and Dr Leanna Wise, discuss key data and their clinical perspectives on these topics.